Phase I Clinical Trial Candidates
Showing 51 - 75 of >10,000
Hip Fractures, Gait Disorders in Old Age Trial in Arganda Del Rey, Madrid (Preliminary Phase, Phase I - Early gait
Enrolling by invitation
- Hip Fractures
- Gait Disorders in Old Age
- Preliminary Phase
- +2 more
-
Arganda Del Rey, Madrid, Spain
- +1 more
Sep 1, 2023
Biliary Carcinoma Trial in Qingdao (TQB3454 tablets)
Not yet recruiting
- Biliary Carcinoma
- TQB3454 tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Nov 15, 2023
Quality of Life Trial in Boston (Quality of Life Intervention)
Not yet recruiting
- Quality of Life
- Quality of Life Intervention
-
Boston, MassachusettsDebra Lundquist
May 2, 2023
Healthy Trial (CM326)
Not yet recruiting
- Healthy
- CM326
- (no location specified)
Jan 27, 2023
Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)
Not yet recruiting
- Advanced Breast Cancer
- Advanced Lung Cancer
- Tumor-infiltrating lymphocytes
- IL-2
- (no location specified)
Oct 26, 2023
Advanced Solid Tumor Trial in Hangzhou (SHR-9839)
Not yet recruiting
- Advanced Solid Tumor
-
Hangzhou, Zhejiang, ChinaZhejiang Tumor Hospital
Apr 19, 2023
Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors Trial in Shanghai (BL-M07D1)
Recruiting
- Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
-
Shanghai, Shanghai, ChinaFudan University ShangHai Cancer Center
Jan 11, 2023
Primary Membranous Nephropathy Trial in Beijing (B007)
Not yet recruiting
- Primary Membranous Nephropathy
-
Beijing, ChinaPeking university first hospital
Dec 20, 2022
Non-hodgkin Lymphoma Trial (HY004)
Not yet recruiting
- Non-hodgkin Lymphoma
- HY004
- (no location specified)
Aug 21, 2023
Diabetes, Type 2 Trial in Changchun (AP026 (TQA2226) for injection, AP026 (TQA2226) for injection matching )
Recruiting
- Diabetes Mellitus, Type 2
- AP026 (TQA2226) for injection
- AP026 (TQA2226) for injection matching placebo
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Nov 16, 2023
Hypertension and Dyslipidemia Trial in Seoul (CKD-348(4) F1, CKD-348(4) F2, CKD-828, D097, D337)
Not yet recruiting
- Hypertension and Dyslipidemia
- CKD-348(4) F1
- +2 more
-
Seoul, Korea, Republic ofH plus Yangji hospital
Sep 18, 2022
Hidradenitis Suppurativa Trial in Granada (Injectable suspension of allogeneic adult mesenchymal stem cells, Placebo)
Recruiting
- Hidradenitis Suppurativa
- Injectable suspension of allogeneic adult mesenchymal stem cells
- Placebo
-
Granada, SpainHospital Universitario Virgen de Las Nieves
Jul 6, 2023
Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)
Recruiting
- Lymphoma, Solid Tumors
- Mitoxantrone Hydrochloride Liposome
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 14, 2022
Kidney Transplantation Trial (SHR-2106 injection or )
Not yet recruiting
- Kidney Transplantation
- SHR-2106 injection or placebo
- (no location specified)
Jul 9, 2023
Advanced Malignant Cancer Trial (SHR-2022 Injection)
Not yet recruiting
- Advanced Malignant Cancer
- SHR-2022 Injection
- (no location specified)
Nov 8, 2023
Healthy Volunteers Trial in Nedlands (VG290131)
Recruiting
- Healthy Volunteers
-
Nedlands, Western Australia, AustraliaLinear Clinical Research Ltd
Oct 17, 2023
Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)
Not yet recruiting
- Leukemia, Myeloid, Acute
- BG1805
-
Guangzhou, Guangdong, China
- +2 more
Nov 1, 2023
Tuberculosis Trial in Seattle (BCG Vaccine USP, Isoniazid)
Active, not recruiting
- Tuberculosis
- BCG Vaccine USP
- Isoniazid
-
Seattle, WashingtonFred Hutchinson Cancer Center
Dec 9, 2022
Knee Osteoarthritis Trial (FURESTEM-OA Kit Inj., Placebo)
Not yet recruiting
- Knee Osteoarthritis
- FURESTEM-OA Kit Inj.
- Placebo
- (no location specified)
Jul 12, 2023
Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- SKG0106
-
Katy, Texas
- +1 more
Aug 15, 2023
Hypertension and Dyslipidemia Trial in Seoul (CKD-348(5), CKD-828, D097, D337)
Not yet recruiting
- Hypertension and Dyslipidemia
- CKD-348(5)
- CKD-828, D097, D337
-
Seoul, Korea, Republic ofH plus Yangji hospital
Feb 20, 2023
Cadmium Exposure Trial in Changsha (GMDTC for injection, Normal saline)
Recruiting
- Cadmium Exposure
- GMDTC for injection
- Normal saline
-
Changsha, Hunan, ChinaHunan Occupational Disease Prevention and Control Institute
Jun 9, 2023